Rules and Regulations. Notice of application
284 words·~1 min read·
/register/2019/02/07/2019-01509A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Kinetochem, LLC ACTION: Notice of application. DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 8, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention:
DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on August 17, 2018, Kinetochem, LLC., 111 W Cooperative Way, Ste. 310-B, Georgetown, Texas 78626 applied to be registered as a bulk manufacturer for the basic classes of controlled substances: Controlled substance Drug code Schedule Marihuana 7360 I Tetrahydrocannabinols 7370 I The company plans to manufacture drug codes 7360 (marihuana) and 7370 (tetrahydrocannabinols), in bulk for distribution and sale to its customers.
The company plans to synthetically manufacture these drugs. No other activities for these drug codes are authorized for this registration. Dated: December 21, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2019-01509 Filed 2-6-19; 8:45 am]
Connectionstraces to 2
2 references not yet in our index
- 21 CFR 1301
- 28 CFR 0
Citation graph
cites case law
Cites 4Cited by 0 across 0 sources